CD274 and non-small cell lung carcinoma: Garon and associates had reported that non-small cell lung cancer patients whose membranous PD-L1 expression was less than 50% had shorter progression-free and overall survival after ICIs treatment comparing to higher PD-L1 expression patients [28].